Frédéric Lortie

Dr. Frédéric Lortie

Laboratoire Ingénierie des Matériaux Polymères, CNRS UMR 5223, INSA Lyon, 69100 Villeurbanne, France
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2018 in Materials
Verified
Journal Article
Open access
PDF file
YRYann Rosetti
Yann Rosetti
PAPierre Alcouffe
Pierre Alcouffe
JPJean-Pierre Pascault
Jean-Pierre Pascault
Jean-François GérardJean-François Gérard
Jean-François Gérard
Frédéric LortieFrédéric Lortie
Frédéric Lortie
The toughness of a high-performance thermosetting epoxy network can be greatly improved by generating polyether sulfone−based macro- to nano-scale morphologies. Two polyethersulfones (PES) which only differ by their chain-end nature have been successively investigated as potential tougheners of a high-Tg thermoset matrix based on a mixture of trifunctional and difunctional aromatic epoxies and an aromatic diamine. For a given PES content, morphologies and toughness of the resulting matrices have been tuned by changing curing conditions and put into perspective with PES chain-end nature.

13 January 2009 in Macromolecular Rapid Communications
Verified
Journal Article
Closed access
PDF file
JBJulien Bernard
Julien Bernard
Frédéric LortieFrédéric Lortie
Frédéric Lortie
BFBernard Fenet
Bernard Fenet

9 June 2022 in Macromolecular Rapid Communications
Verified
Journal Article
Open access
SCSenbin Chen
Senbin Chen
YWYanggui Wu
Yanggui Wu
Frédéric LortieFrédéric Lortie
Frédéric Lortie
JBJulien Bernard
Julien Bernard
WBWolfgang Binder
Wolfgang Binder
JZJintao Zhu
Jintao Zhu
Among the various challenges in medicine, diagnosis, complete cure, and healing of cancers remain difficult given the heterogeneity and complexity of such a disease. Differing from conventional platforms with often unsatisfactory theranostic capabilities, the contribution of supramolecular interactions, such as hydrogen‐bonds (H‐bonds), to cancer nanotheranostics opens new perspectives for the design of biomedical materials, exhibiting remarkable properties and easier processability. Thanks to their dynamic characteristics, a feature generally observed for noncovalent interactions, H‐bonding (macro)molecules can be used as supramolecular motifs for yielding drug‐ and diagnostic carriers that possess attractive features, arising from the combination of assembled nanoplatforms and the responsiveness of H‐bonds. Thus, H‐bonded nanomedicine provides a rich toolbox that is useful to fulfill biomedical needs with unique advantages in early‐stage diagnosis and therapy, demonstrating the promising potential in clinical translations and applications. Here the design and synthetic routes toward H‐bonded nanomedicines, focus on the growing understanding of the structure‐function relationship for efficient cancer treatment are summarized. A guidance for designing new H‐bonded intelligent theranostic agents is proposed, to inspire more successful explorations of cancer nanotheranostics and finally to promote potential clinical translations.

18 December 2018 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
QCQuentin Charlier
Quentin Charlier
JFJean‐Charles Fontanier
Jean‐Charles Fontanier
Frédéric LortieFrédéric Lortie
Frédéric Lortie
JPJean‐Pierre Pascault
Jean‐Pierre Pascault
JGJean‐François Gerard
Jean‐François Gerard